Searching for structures with analogs of Ruboxistaurin.

Search results (27 entries covering 13 PDB structures)

#KinaseFamilyGroupPDBChain(Alternate) Model Orthosteric ligandOrganismDetailsSimilarity (MFP)File
GSK3BGSKCMGC2ow3Abis-(indole)maleimide pyridinophaneHuman6980.48
DMPK (DMPK1)DMPKAGC2vd5A3-[1-(3-aminopropyl)-1h-indol-3-yl]-4-(1-methyl-1h-indol-3-yl)-1h-pyrrole-2,5-dioneHuman19010.41
PIM1PIMCAMK2bikBA3-{1-[3-(dimethylamino)propyl]-1h-indol-3-yl}-4-(1h-indol-3-yl)-1h-pyrrole-2,5-dioneHuman23410.41
PIM1PIMCAMK1xwsAA3-{1-[3-(dimethylamino)propyl]-1h-indol-3-yl}-4-(1h-indol-3-yl)-1h-pyrrole-2,5-dioneHuman23430.41
PIM1PIMCAMK2j2iBA(9r)-9-[(dimethylamino)methyl]-6,7,10,11-tetrahydro-9h,18h-5,21:12,17-dimethenodibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecine-18,20-dioneHuman23181.00
PIM1PIMCAMK2j2iBB(9r)-9-[(dimethylamino)methyl]-6,7,10,11-tetrahydro-9h,18h-5,21:12,17-dimethenodibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecine-18,20-dioneHuman24341.00
PIM1PIMCAMK1xwsAB3-{1-[3-(dimethylamino)propyl]-1h-indol-3-yl}-4-(1h-indol-3-yl)-1h-pyrrole-2,5-dioneHuman24410.41
PIM1PIMCAMK2bilB3-{1-[3-(dimethylamino)propyl]-1h-indol-3-yl}-4-(1h-indol-3-yl)-1h-pyrrole-2,5-dioneHuman24490.41
PIM1PIMCAMK2bikBB3-{1-[3-(dimethylamino)propyl]-1h-indol-3-yl}-4-(1h-indol-3-yl)-1h-pyrrole-2,5-dioneHuman24630.41
PDPK1 (PDK1)PDK1AGC3orzCA3-(1h-indol-3-yl)-4-{1-[2-(1-methylpyrrolidin-2-yl)ethyl]-1h-indol-3-yl}-1h-pyrrole-2,5-dioneHuman31500.41
PDPK1 (PDK1)PDK1AGC1uu3AA(9r)-9-[(dimethylamino)methyl]-6,7,10,11-tetrahydro-9h,18h-5,21:12,17-dimethenodibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecine-18,20-dioneHuman31801.00
PDPK1 (PDK1)PDK1AGC3orzBA3-(1h-indol-3-yl)-4-{1-[2-(1-methylpyrrolidin-2-yl)ethyl]-1h-indol-3-yl}-1h-pyrrole-2,5-dioneHuman31600.41
PDPK1 (PDK1)PDK1AGC1uu7A3-(1h-indol-3-yl)-4-(1-{2-[(2s)-1-methylpyrrolidinyl]ethyl}-1h-indol-3-yl)-1h-pyrrole-2,5-dioneHuman32240.41
PDPK1 (PDK1)PDK1AGC1uvrA3-[1-(3-aminopropyl)-1h-indol-3-yl]-4-(1-methyl-1h-indol-3-yl)-1h-pyrrole-2,5-dioneHuman31930.41
PDPK1 (PDK1)PDK1AGC3orzBB3-(1h-indol-3-yl)-4-{1-[2-(1-methylpyrrolidin-2-yl)ethyl]-1h-indol-3-yl}-1h-pyrrole-2,5-dioneHuman31980.41
PDPK1 (PDK1)PDK1AGC3orzCB3-(1h-indol-3-yl)-4-{1-[2-(1-methylpyrrolidin-2-yl)ethyl]-1h-indol-3-yl}-1h-pyrrole-2,5-dioneHuman32430.41
PDPK1 (PDK1)PDK1AGC1uu8AA3-{1-[3-(dimethylamino)propyl]-1h-indol-3-yl}-4-(1h-indol-3-yl)-1h-pyrrole-2,5-dioneHuman32390.41
PDPK1 (PDK1)PDK1AGC1uu3AB(9r)-9-[(dimethylamino)methyl]-6,7,10,11-tetrahydro-9h,18h-5,21:12,17-dimethenodibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecine-18,20-dioneHuman32481.00
PRKCI (PKCi)PKCAGC1zrzA3-{1-[3-(dimethylamino)propyl]-1h-indol-3-yl}-4-(1h-indol-3-yl)-1h-pyrrole-2,5-dioneHuman33540.41
PDPK1 (PDK1)PDK1AGC3orzAA3-(1h-indol-3-yl)-4-{1-[2-(1-methylpyrrolidin-2-yl)ethyl]-1h-indol-3-yl}-1h-pyrrole-2,5-dioneHuman31970.41
PDPK1 (PDK1)PDK1AGC3otuA3-(1h-indol-3-yl)-4-{1-[2-(1-methylpyrrolidin-2-yl)ethyl]-1h-indol-3-yl}-1h-pyrrole-2,5-dioneHuman32170.41
PDPK1 (PDK1)PDK1AGC1uu8AB3-{1-[3-(dimethylamino)propyl]-1h-indol-3-yl}-4-(1h-indol-3-yl)-1h-pyrrole-2,5-dioneHuman32370.41
GSK3BGSKCMGC2ow3Bbis-(indole)maleimide pyridinophaneHuman6490.48
DMPK (DMPK1)DMPKAGC2vd5B3-[1-(3-aminopropyl)-1h-indol-3-yl]-4-(1-methyl-1h-indol-3-yl)-1h-pyrrole-2,5-dioneHuman19020.41
PDPK1 (PDK1)PDK1AGC3orzDB3-(1h-indol-3-yl)-4-{1-[2-(1-methylpyrrolidin-2-yl)ethyl]-1h-indol-3-yl}-1h-pyrrole-2,5-dioneHuman31840.41
PDPK1 (PDK1)PDK1AGC3orzDA3-(1h-indol-3-yl)-4-{1-[2-(1-methylpyrrolidin-2-yl)ethyl]-1h-indol-3-yl}-1h-pyrrole-2,5-dioneHuman31920.41
PDPK1 (PDK1)PDK1AGC3orzAB3-(1h-indol-3-yl)-4-{1-[2-(1-methylpyrrolidin-2-yl)ethyl]-1h-indol-3-yl}-1h-pyrrole-2,5-dioneHuman31810.41